ApiFix is developing a truly breakthrough minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis (AIS).
The minimally invasive ApiFix system incorporates a miniature ratchet mechanism that captures incremental corrections performed by the patient according to the physical therapy regimen. The deformity correction process spans several months to allow the soft tissues to accommodate any minor correction. The ApiFix system is inserted through a small incision in the patient’s back and uses only two screws to support its ratchet-based, small expandable rod.
The ApiFix system has been used on 166 patients (as of 30 September 2017).
Stage: Revenue (commercial sales in 9 countries); 5 distribution agreements (Canada, Spain, Holland, Greece, Singapore)
Investors: The Trendlines Group, B. Braun
IP: 7 families of granted and pending patents
Certification: CE mark
2016, National Capital Consortium for Pediatric Device Innovation (NCC-PDI) Competition Winner
2012, Best Start-Up, Israel’s Office of the Chief Scientist of the Ministry of Economy
Today’s gold standard for correcting spinal deformities involves fusing an average of 10 motion levels using a large number of screws in a surgical procedure that lasts an average of six hours and costs upward of $100,000. There are approximately 80,000 surgeries to repair spinal deformities performed annually worldwide. The cost of scoliosis correction implants in the United States, not including hospitalization, is around $600 million annually, with an estimated $300 million market outside the United States.
Preventing catheter-associated urinary tract infections (CAUTIs)
Wireless, wearable vital sign monitoring system
Cryotherapy for superficial bladder cancer
Endoscopic ultrasound fine needle biopsy
Portable, automatic system for peritoneal dialysis
Device for treating ischemic stroke